$AMGN.d
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Ph...
Stocks
$9.41
$405
▲+11.41%from 30d ago
1
$9.41
Tokenized Stock Metrics
Metric
Show % of Total
Market Cap by Network
as of 08/12/2026
Key Facts
Name
Amgen Inc. Common Stock
Ticker
AMGN.d
CUSIP
—
ISIN
—
Platform
Tokenization Type
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
—
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
$9
△
NAV
$405
▲
Price
—
Token Supply
0.02
△
Circulating Supply
0.02
△
7D APY
—
30D APY
—
Holders
1
△
Trailing 30D Active Addresses
1
△
Monthly Transfer Count
1
△
Monthly Transfer Volume
$9
△
Tokens
Primary Market
Eligible Investors
—
Base Assets
—
Subscription Time
—
Min. Investment
—
Subscription Fees
0%
Subscription Description
—
Redemption Time
—
Minimum Redemption Amount
—
Redemption Fees
0%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
Dinari
Issuer LEI
—
Issuer CIK
Domicile
United States of America
Regulatory Framework
U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0%
Subscription Fees
0%
RWA.xyzAll Rights Reserved